Infliximab to Treat Non-Infectious Scleritis

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 23, 2003

Study Completion Date

September 6, 2007

Conditions

Scleritis

Interventions

DRUG

Infliximab

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00075075 - Infliximab to Treat Non-Infectious Scleritis | Biotech Hunter | Biotech Hunter